Belimumab

LP-176 SARS-CoV-2 antibody formation after COVID-19 vaccination in SLE patients treated with belimumab: single-center prospective observational study
Eunsong Kang, Soo Min Ahn, Seokchan Hong, Ji Seon Oh, Chang Keun Lee, Bin Yoo, Yong Gil Kim

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A151; DOI: 10.1136/lupus-2023-KCR.251
LSO-065 Belimumab in combination with antimalarial agents prevent renal flares in patients with systemic lupus erythematosus and moderate-to-high extra-renal activity: results from four randomised clinical trials
Alvaro Gomez, Sandra Jägerback, Christopher Sjöwall, Ioannis Parodis

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A75; DOI: 10.1136/lupus-2023-KCR.107
LSO-066 Spanish national regsitry of belimumab in patients with systemic lupus erythematosus
Vicente Aldasoro, María Laiño, Mónica Enguita, Javier Loricera, Clara Moriano, Carmen Lasa, Vanesa Calvo, Francisco Javier Narváez, Pablo Navarro, Ivette Casafont, Judit Font, Adela Gállego, Irene Carrión, Patricia Quiroga, Santos Castañeda, Ángel García, Joaquín Belzunegui, Juán Ramón de Dios, Samuel Hernández, Sergi Heredia, Aaron Fariña, Francisco Navarro, Rafaela Ortega, Leticia del Olmo, Valvanera Pinillos, Eztizen Labrador, María Carmen Ortega, Patricia Castro, Juan Blanco, Marcos Paulino, María Ángeles Matías, Cilia Peralta, Silvia García, Jordi Camins, Ana Urruticoechea, Miguel Medina, Piter Cossio, Eva Pérez, Blanca Varas, Carlos Vázquez, Nuria Vegas, Olga Rusinovich, Emilio Giner, José Ramón Lamúa

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A76; DOI: 10.1136/lupus-2023-KCR.108
LSO-068 Association between organ-specific safety of estrogens in lupus erythematosus national assessment-systemic lupus erythematosus (SLE) disease activity index (SELENA-SLEDAI) response to belimumab and SF-36v2 and FACIT-fatigue scores in patients with SLE
Regina Rendas-Baum, Wen-Hung Chen, Seth Anderson, Christine Henning, Anne Hammer, Mark Kosinski

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A77-A78; DOI: 10.1136/lupus-2023-KCR.109
LSO-069 Satisfaction and effectiveness of switching from intravenous to subcutaneous belimumab treatment in daily clinical practice
Beatriz Frade-Sosa, Tarek Carlos Salman-Monte, Javier Narváez, Irene Peralta, Sebastian Sandoval, Berta Magallares, Sergi Heredia, Nuria Sapena, Anne Riveros-Frutos, Alex Olivé, Hector Corominas, Josefina Cortés-Hernández, Jose A Gómez-Puerta

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A78-A79; DOI: 10.1136/lupus-2023-KCR.110
LSO-088 Ld-IL2 synthesis with belimumab in the treatment of systemic lupus erythematosus patients
Ruiling Feng

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A89-A90; DOI: 10.1136/lupus-2023-KCR.129
LP-170 Predictors of neuropsychiatric flares In Patients With Systemic Lupus Erythematosus: Results From Five Phase III clinical trials of belimumab
Leonardo Palazzo, Julius Lindblom, Nursen Cetrez, Henri Ala, Ioannis Parodis

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A149; DOI: 10.1136/lupus-2023-KCR.246
LP-181 Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus
Masato Okada

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A154-A155; DOI: 10.1136/lupus-2023-KCR.256
LP-186 Initial experience with belimumab In SE Asian lupus patients – a report of 6 patients
YOONKam hon, Wong Nadia

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A158; DOI: 10.1136/lupus-2023-KCR.261
LO-043 Single-cell RNA sequencing reveals the dynamics of circulating immune cells in SLE patients treated with belimumab
Christine Suh-Yun Joh, So-Young Bang, Sang-Cheol Bae, Hyun Je Kim, Hye-Soon Lee

Lupus Science & Medicine Jul 2023, 10 (Suppl 1) A19-A20; DOI: 10.1136/lupus-2023-KCR.23

Main menu

Belimumab

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Belimumab

Pages